RxDoctor Payments Data

Ana Loza, NP

Primary Care · Pontiac, MINPI 1932851631

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. KCI USA, Inc. accounts for 74.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $2,826 and has fallen 92.3% since, to $218 in 2025.

$3,167in general payments, 2019–2025

Across 19 payments — averaging $166.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • KCI USA, Inc.$2K
  • Hollister Incorporated$152
  • SK Life Science, Inc.$125
  • Gilead$122
  • Convatec Inc.$111
  • Hydrofera LLC$91
  • plus $218 from 6 others

What the payments were for

  • Food & beverage$3,167100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
KCI USA, Inc.6$2,348
Hollister Incorporated1$152
SK Life Science, Inc.1$125
Gilead1$122
Convatec Inc.1$111
Hydrofera LLC2$91
Smith+Nephew1$90
AbbVie2$38
Cipher Pharmaceuticals US LLC1$32
Urgo Medical North America, LLC1$25
Exact Sciences1$18
Hartmann USA, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,167 in reported general payments places this provider in the 85th percentile of 292 primary care providers in Michigan.

See all primary care providers in Michigan

Medicare billing

Part B allowed, 2024
$5,185
Medicare patients
48
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate12$365
Atorvastatin Calcium24$222
Metformin Hcl30$199
Tamsulosin Hcl18$147
Gabapentin11$140
ClopidogrelClopidogrel Bisulfate13$100
Lisinopril16$85
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide19$65
Amlodipine Besylate17$54

Paid to pharmacies, not to this prescriber.

Other primary care in Pontiac

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →